ATMPs: EU Needs To Shift Mindset From ‘Zero-Risk’ To ‘Measured Approach’

 
• By Eliza Slawther
  
There are some situations in which the EU should be willing to take more risk when it comes to ATMPs
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Cell & Gene Therapies

More from Advanced Technologies